
Should You Buy the BioStem Technologies IPO? Here's the Setup
BioStem Technologies, Inc. (NASDAQ: BSEM) is expected to list on 2026-08-07, but the price range has not been disclosed. The company is coming to market through an expected Nasdaq uplisting rather than a traditional IPO prospectus. The bull case is a high-margin wound-care platform; the bear case is heavy customer concentration and a 2025 revenue drop.
